Am I a Candidate for Valeda Treatment for Dry AMD?
Valeda is a light-based therapy that research suggests may help slow the progression of dry age-related macular degeneration (AMD), and patients across the Snellville, GA area are increasingly asking whether they may be candidates. If you or someone you care about has received a dry AMD diagnosis, understanding how Valeda works, who may benefit, and what to expect from the process is an important first step. This page is designed to answer those questions in plain language, so you can walk into your next conversation with an eye care provider feeling informed and prepared. To speak with our team directly, call us for details.
Understanding Dry AMD and Why Valeda Treatment Is Generating Interest
Age-related macular degeneration is one of the leading causes of vision loss among adults over 50, and the dry form accounts for the majority of AMD cases. Dry AMD develops when the light-sensitive cells in the macula gradually deteriorate, often leading to blurred central vision, difficulty reading, and challenges recognizing faces. Unlike wet AMD, dry AMD has historically had fewer treatment options available, which is part of why Valeda treatment has generated significant attention in the ophthalmology community.
Valeda uses a precisely calibrated sequence of low-level light wavelengths, a process known as photobiomodulation, to stimulate cellular activity in the retina. Research suggests this approach may help support the health of retinal cells and reduce the accumulation of drusen, the protein and lipid deposits that are a hallmark of early to intermediate dry AMD. For patients and families navigating this diagnosis, learning more about macular degeneration treatment options in Atlanta and Gwinnett County is a natural and important part of that journey.
Am I a Candidate for Valeda? Key Factors Your Provider Will Consider
Candidacy for Valeda treatment is not determined by a single factor. Your provider will conduct a thorough evaluation that considers the stage of your dry AMD, the health of your retina, and your overall eye health history. Current evidence suggests Valeda may be most beneficial for patients with early to intermediate dry AMD, sometimes described as the stage before significant central vision loss has occurred.
Factors That May Support Candidacy
Research suggests patients who may be well-suited for Valeda treatment often share certain characteristics. These can include a confirmed diagnosis of dry AMD at an early or intermediate stage, the presence of drusen identified through retinal imaging, and relatively preserved central vision. Your provider will also consider whether you have other retinal conditions that could affect your response to photobiomodulation therapy.
Conditions That May Affect Eligibility
Valeda may not be appropriate for all patients. Those with wet AMD, certain retinal disorders, or a history of prior retinal treatments may require a more individualized discussion. Patients who experience symptoms such as sudden changes in vision, new floaters, or flashes of light should seek prompt evaluation. You can learn more about related symptoms by reviewing information on floaters and flashes in Atlanta and Gwinnett County.
A comprehensive dilated eye examination and advanced retinal imaging are typically part of the candidacy assessment. Individual results may vary, and a consultation with an experienced ophthalmologist is the most reliable way to determine whether Valeda may be a suitable option for your specific situation.
What to Expect From the Valeda Treatment Process in Snellville, GA
For patients who are confirmed candidates, the Valeda treatment process is generally well-tolerated and does not require surgery or injections. Each session involves the patient looking into the Valeda device while the calibrated light sequences are delivered to the retina. Sessions are typically brief, and most patients can resume normal daily activities immediately following the appointment, though individual experiences may differ.
Treatment Schedule and Follow-Up
Valeda is typically administered as a series of sessions over a defined period, with the specific schedule determined by your provider based on your clinical presentation. Follow-up evaluations allow your care team to monitor your retinal health and assess your response to treatment over time. Consistent attendance and ongoing communication with your provider are important parts of the process.
Integrating Valeda Into Your Broader Eye Health Plan
Valeda is generally considered one component of a broader approach to managing dry AMD, rather than a standalone solution. Patients managing other systemic conditions such as diabetes should ensure their full medical picture is shared with their eye care team, as conditions like diabetic retinopathy can affect retinal health. More information on diabetic retinopathy and treatment in Atlanta and Gwinnett County is available for patients who may be managing both concerns.
Our practice takes a whole-patient approach to eye care, which means your Valeda discussion will be situated within a complete understanding of your vision health history. Individual results may vary.
Why Choose CarlinVision in Snellville, GA?
CarlinVision has served patients in Gwinnett County and the greater Atlanta area for over 42 years, earning a reputation as the largest and most experienced eye care practice in the region. Our physicians include multiple Diplomates of the American Board of Ophthalmology and Fellows of the American Academy of Ophthalmology, and our practice is affiliated with professional organizations including the American Society of Cataract and Refractive Surgery and the Association for Research in Vision and Ophthalmology.
What sets our practice apart is the breadth and depth of specialty care available under one roof. We treat every patient as a neighbor, not a number, and we bring that same commitment to every Valeda candidacy consultation. We invite you to meet our team of doctors and learn more about the experience behind your care.
Frequently Asked Questions About Valeda
Is Valeda covered by insurance?
Coverage for Valeda treatment varies by insurance plan and is subject to change. Because this is a relatively newer therapy, it may not be covered under all plans at this time. We encourage patients to contact our office directly and to check with their insurance provider ahead of their consultation. Our team can help guide you through the process of understanding your benefits and available options.
Can Valeda restore vision that has already been lost to dry AMD?
Research suggests Valeda may help support retinal cell health and potentially stop progression of early to intermediate dry AMD, but it is not considered a treatment designed to restore vision that has already been lost. The goal of therapy is generally stabilization and support rather than reversal. Your ophthalmologist will provide a realistic picture of what outcomes may be possible based on your current retinal health. Individual results may vary.
Is Valeda treatment painful or uncomfortable?
Valeda is generally well-tolerated by most patients. The treatment involves looking into a device that delivers calibrated light sequences to the retina and does not require anesthesia, injections, or incisions. Most patients report the experience as comfortable and straightforward. Your provider will walk you through exactly what to expect before your first session so you feel informed and at ease throughout the process.
Where can I learn more about AMD and other retinal conditions treated at your practice?
Our practice offers comprehensive retinal care, and our website includes resources on a range of related topics. You can explore information on macular degeneration treatment in Atlanta and Gwinnett County as a starting point. For additional reading and updates from our clinical team, visit the CarlinVision blog. We encourage patients to come to consultations with their questions ready.
If you are researching Valeda in Snellville, GA, and wondering whether you or a loved one may be a candidate for this therapy, the next step is a conversation with an experienced ophthalmologist. Our team at CarlinVision is here to provide the thorough evaluation and honest guidance you deserve. Call us to schedule your consultation and take the first step toward understanding your options.
Dr. Carlin is a highly experienced, board-certified ophthalmologist and Diplomate of the American Board of Ophthalmology with more than five decades of experience in vision care and surgical innovation. A graduate of the University of Illinois College of Medicine, he completed his ophthalmology residency at the University of Michigan before serving in the United States Navy in Key West, Florida. In 1977, he founded CarlinVision and has since built a longstanding reputation for excellence in LASIK, cataract surgery, refractive procedures, and cosmetic eyelid surgery. Throughout his career, Dr. Carlin has completed more than 11,000 procedures and remains at the forefront of advanced laser and refractive technologies. He is a Fellow of the American Academy of Ophthalmology and an active member of multiple leading professional organizations, reflecting his enduring commitment to clinical excellence and patient care.
